Results 11 to 20 of about 1,348,486 (207)

Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial

Arthritis Research & Therapy, 2018
BackgroundThe aim was to analyze characteristics that predict remission induction and subsequent loss of remission in patients with moderately active rheumatoid arthritis (RA) who received full-dose combination etanercept plus methotrexate induction ...
J. Smolen, A. Szumski, A. Koenig, T. Jones, L. Marshall   +4 more
semanticscholar   +3 more sources

Prediction of response to remission induction therapy by gene expression profiling of peripheral blood in Japanese patients with microscopic polyangiitis

Arthritis Research & Therapy, 2017
BackgroundMicroscopic polyangiitis (MPA), which is classified as an anti-neutrophil cytoplasmic antibody (ANCA)-associated small vessel vasculitis, is one of the most frequent primary vasculitides in Japan.
A. Ishizu, U. Tomaru, S. Masuda, K. Sada, K. Amano, M. Harigai, Y. Kawaguchi, Y. Arimura, K. Yamagata, S. Ozaki, H. Dobashi, S. Homma, Y. Okada, H. Sugiyama, Joichi Usui, N. Tsuboi, S. Matsuo, H. Makino   +17 more
semanticscholar   +3 more sources

Antibiotics for induction and maintenance of remission in Crohn's disease.

Cochrane Database of Systematic Reviews, 2017
BACKGROUND Several antibiotics have been evaluated in Crohn's disease (CD), however randomised controlled trials (RCTs) have produced conflicting results.
C. Townsend, C. Parker, J. Macdonald, Tran M Nguyen, V. Jairath, B. Feagan, R. Khanna   +6 more
semanticscholar   +3 more sources

Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapy [PDF]

British Journal of Haematology, 2015
Seth E. Karol, E. Coustan-Smith, Xueyuan Cao, S. Shurtleff, S. Raimondi, J. Choi, Raul C. Ribeiro, G. Dahl, W. Bowman, J. Taub, B. Degar, W. Leung, J. Downing, C. Pui, J. Rubnitz, D. Campana, H. Inaba   +16 more
semanticscholar   +2 more sources

Serum ferritin is a good indicator for predicting the efficacy of adult HLH induction therapy

Annals of Medicine, 2022
Background: Hemophagocytic lymphohistiocytosis (HLH) is a rare clinical syndrome with a high mortality rate. There is no biomarker to predict the early therapeutic response.
Zhengjie Hua, Lingbo He, Ruoxi Zhang, Menghan Liu, Zhao Wang, Yini Wang   +5 more
doaj   +1 more source

Remission after Six Months of Induction Immunosuppressive Treatment with Mycofenolate Mofetil and Prednisolone in Patients with Lupus Nephritis: A Descriptive Cross-sectional Study

Journal of Nepal Medical Association, 2021
Introduction: Treatment of lupus nephritis consists of six months of induction immunosuppression followed by years of maintenance immunosuppression.
Shailendra Shrestha, Rahul Yadav
doaj   +1 more source

Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study [PDF]

Intestinal Research, 2021
Background/Aims The efficacy and safety of vedolizumab in moderate to severely active ulcerative colitis (UC) have been demonstrated in the GEMINI 1 study (NCT00783718).
Choon Jin Ooi, Ida Normiha Hilmi, Hyo-Jong Kim, Umesh Jalihal, Deng-Chyang Wu, Dirk Demuth, Dirk Lindner, Shashi Adsul   +7 more
doaj   +1 more source

Efficacy and safety of methotrexate in the management of inflammatory bowel disease: A systematic review and meta-analysis of randomized, controlled trials

EClinicalMedicine, 2020
Background: The therapeutic role of methotrexate (MTX) for management of inflammatory bowel disease (IBD) remains unclear. Methods: We systematically reviewed randomized, controlled trials (RCTs) of MTX for induction and maintenance of remission in IBD ...
Ole Haagen Nielsen, Casper Steenholdt, Carsten Bogh Juhl, Gerhard Rogler   +3 more
doaj   +1 more source

A case of regression of atypical dense deposit disease without C3 deposition in a child [PDF]

Korean Journal of Pediatrics, 2010
Dense deposit disease (DDD) is a rare disorder characterized by the deposition of abnormal electron-dense material within the glomerular basement membrane of the kidneys. The diagnosis is made in most patients between 5 and 15 years of age, and within 10
Min Sun Kim, Pyoung Han Hwang, Mung Jae Kang, Dae-Yeol Lee   +3 more
doaj   +1 more source

An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation

Haematologica, 2016
Up to 30% of adults with acute myeloid leukemia fail to achieve a complete remission after induction chemotherapy - termed primary refractory acute myeloid leukemia.
Paul Ferguson, Robert K. Hills, Angela Grech, Sophie Betteridge, Lars Kjeldsen, Michael Dennis, Paresh Vyas, Anthony H. Goldstone, Donald Milligan, Richard E. Clark, Nigel H. Russell, Charles Craddock   +11 more
doaj   +1 more source